Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Total 13F shares
-
56,638,847
-
Share change
-
+1,976,064
-
Total reported value
-
$1,582,549,935
-
Put/Call ratio
-
68%
-
Price per share
-
$28.00
-
Number of holders
-
155
-
Value change
-
+$86,587,280
-
Number of buys
-
78
-
Number of sells
-
85
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q3 2025
As of 30 Sep 2025,
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) was held by
155 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,638,847 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Avoro Capital Advisors LLC, JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, BVF INC/IL, BAKER BROS. ADVISORS LP, Casdin Capital, LLC, RA CAPITAL MANAGEMENT, L.P., and MILLENNIUM MANAGEMENT LLC.
This page lists
155
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.